History
1500 stored umbilical cord blood and umbilical cord tissue
Cell CooLab Ostrava
Commencement of the AMNIODERM® production
AMNIODERM® is a lyophilized human amniotic membrane (dHAM). It is one of the fetal membranes which is processed by patented procedure AMNIPUR®. It contains a huge amount of proteins, growth factors, cytokines and other specific molecules present in perinatal tissues.
Penta Investments acquired a minority stake in PrimeCell Advanced Therapy
SCL Biological Czech s.r.o.
The establishment of joint-venture SCL Biological Czech s.r.o. with chines biotechnological company SCL Biotechnology Co., Ltd.
4Medical Innovations (4MEDi)
The opening of the 4Medical Innovations (4MEDi) Bio-medical park in Ostrava – investment of USD 60 mil. Alltogether there is 6 800 m² of laboratory space for regenerative medicine.
Commencement of the NTC chondrograft® production – ATMP
Commencement of the Tissue transplants production
Know-how of Advanced Therapy Medicinal Products (ATMPs)
The acquirement of the copyright for manufacturing know-how of Advanced Therapy Medicinal Products (ATMPs).
Commencement of co-operation with another research organisations
Commencement of co-operation with another research organisations, such as The University Hospital of Kings Wineyard Prague and its Faculty of Medicine; The University Hospital Ostrava and its Faculty of Medical; Medical Institute Ostrava; and the General University hospital in Prague.
Development of specialised technologies
Commencement of the development of unique, specialised technologies for transplantology and nanomaterials.
National Cell and Tissue Centre
The opening of the National Cell and Tissue Centre in Brno – investment of USD 30 mil.
Commencement of co-operation with the University hospital Brno
The acquisition of the “Czech 100 Best” award for invention and innovation. Commencement of co-operation with the Institute of experimental medicine Academy of Science, Czech Republic.
The establishment of PrimeCell Therapeutics
The establishment of PrimeCell Therapeutics. Major investments into research on the field of regenerative medicine.
Preparations for the establishment of PrimeCell Therapeutics
The acquisition of know-how and the Intellectual Property Rights for the initial products of PrimeCell Therapeutics.
